References
- Grahmann H, Suchenwirth R. Thrombose hazard in chlorpromazine and reserpine therapy of endogenous psychosis. Nervenarzt 1959; 30: 224–5
- Zornberg GI, Jick H. Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case control study. Lancet 2000; 356: 1219–23
- Kortepeter C, Chen M, Knudsen JF, Dubitsky GM, Ahmad SR, Beitz J. Clozapine and venous thromboembolism. Am J Psychiatry 2002; 159: 876–7
- Kamijo Y, Soma K, Nagai T, Kurihara K, Ohwada T. Acute massive pulmonary thromboembolism associated with risperidone and conventional phenothiazines. Circ J 2003; 67: 46–8
- Hägg S, Tatting P, Spigset O. Olanzapine and venous thromboembolism. Int Clin Psychopharmacol 2003; 18: 299–300
- American College of Neuropsychopharmacology. Neuropsychopharmacology. The fifth generation of progress. 1st ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2002.
- Marder SR, van Kammen DP. Dopamine receptor antagonists. Comprehensive textbook of psychiatry. 7th ed, BJ Sadock, VA Sadock. Lippincott Williams & Wilkins, Philadelphia, PA 2000; 2356–77
- American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity. Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes. Diabetes Care 2004;27:596–601.
- Abdollahi M, Cushman M, Rosendaal FR. Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use. Thromb Haemost 2003; 89: 493–8
- Hägg S, Spigset O, Söderström TG. Association of venous tromboembolism and clozapine. Lancet 2000; 355: 1155–6
- Firer M, Sirota P, Schild K, Elizur A, Slor H. Anticardiolipin antibodies are elevated in drug-free, multiply affected families with schizophrenia. J Clin Immunol 1994; 14: 73–8
- Canoso RT, Oliveira RM, Nixon RA. Neuroleptic-associated autoantibodies. A prevalence study. Biol Psychiatry 1990; 27: 863–70
- Alhenc-Gelas M, Aiach M, de Moerloose P. Venous thromboembolic disease: risk factors and laboratory investigation. Semin Vasc Med 2001; 1: 81–7
- Rosendaal FR. Risk factors for venous thrombotic disease. Thromb Haemost 1999; 82: 610–9
- Song, C, Leonard, BE. Fundamentals of psychoneuroimmunology. 1st ed. Chichester: John Wiley & Sons; 2000.
- Applebaum J, Shimon H, Sela BA, Belmaker RH, Levine J. Homocysteine levels in newly admitted schizophrenic patients. J Psychiatr Res 2004; 38: 413–6
- Knudsen JF, Kortepeter C, Dubitsky GM, Ahmad SR, Chen M. Antipsychotic drugs and venous thromboembolism (letter). Lancet 2000; 356: 252–3
- Liperoti R, Pedone C, Lapane KL, Mor V, Bernabei R, Gambassi G. Venous thromboembolism among elderly patients treated with atypical and conventional antipsychotic agents. Arch Intern Med 2005; 165: 2677–82